Lion Point Capital, LP
•CIK: 1643354•Filing: Q4 2025
**Lion Point Capital, LP** manages $19M across a concentrated portfolio of 39 positions. The fund exhibits notable conviction in technology and specialized sectors, with top holdings including MIST at $1.5M and PRAX at $1.3M. Further significant allocations are maintained in MLTX, FRX, and JSPR, each representing substantial capital deployment. This structure suggests a focused, high-conviction approach within its current investment mandate.
Total AUM
$19.3M
QoQ Performance
+9.8%
Positions
39
Top 10 Concentration
48.5%
Latest Filing
Q4 2025
Top Holdings Allocation
MIST
PRAX
MIST7.9%
PRAX6.8%
MLTX4.6%
FRX4.5%
JSPR4.4%
BNTC4.3%
RPRX4.3%
GON3.9%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q3 2025
—
AVADEL PHARMACEUTICALS PLC
SOLD
$911.6K
—
KINIKSA PHARMACEUTICALS INTL
SOLD
$908.6K
Changes from Q3 2025
NEW15 new positions
↑6 increased
↓10 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023